Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Queensland Health
Chubb
QuintilesIMS
Cantor Fitzgerald
Fish and Richardson
McKinsey
Merck
UBS

Generated: June 24, 2018

DrugPatentWatch Database Preview

HALOPERIDOL DECANOATE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Haloperidol Decanoate, and what generic alternatives are available?

Haloperidol Decanoate is a drug marketed by Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Mylan Labs Ltd, Sandoz Inc, Teva Pharms Usa, and West-ward Pharms Int. and is included in eight NDAs.

The generic ingredient in HALOPERIDOL DECANOATE is haloperidol decanoate. There are twenty drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.
Drug patent expirations by year for HALOPERIDOL DECANOATE
Pharmacology for HALOPERIDOL DECANOATE
Synonyms for HALOPERIDOL DECANOATE
[4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] decanoate
4- -1-[4- -4-oxobutyl]-4-piperidyldecanoate
4-(4-Chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidyl decanoate
74050-97-8
77129-05-6
AC1L1DVL
AC20PJ4101
AKOS025392169
API0024496
BDBM50053408
C31H41ClFNO3
CHEBI:31664
CHEMBL1200986
CTK5D9276
D01898
DECANOIC ACID 4-(4-CHLOROPHENYL)-1-[4-(4-FLUOROPHENYL)-4-OXOBUTYL]-4-PIPERIDINYL ESTER
Decanoic acid, 4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl ester
Decanoic acid, ester with 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
Depot haloperidol
DTXSID50224951
EINECS 277-679-7
FT-0669103
Haldol Dec
Haldol decanoas
Haldol decanoate
Halomonth
Halomonth (TN)
Haloperidol decanoate (JAN/USAN)
Haloperidol decanoate [USAN:BAN:JAN]
Haloperidol decanoate [USAN:USP:BAN:JAN]
Haloperidol Decanoate HCl
Haloperidol depot
KD 136
KD 16
KD-136
KS-1419
LP016102
LS-59345
MolPort-006-137-967
R 13,672
R 13672
R 13762
R-13,672
R-13672
SCHEMBL120575
UNII-AC20PJ4101
W0040
ZINC8214574

US Patents and Regulatory Information for HALOPERIDOL DECANOATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 074893-001 Dec 19, 1997 AO RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Labs Ltd HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 075440-001 Feb 28, 2000 AO RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Gland Pharma Ltd HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 205241-002 May 12, 2017 AO RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms Usa HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 075393-002 May 11, 1999 AO RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Deloitte
Cerilliant
AstraZeneca
Chubb
Harvard Business School
Mallinckrodt
Accenture
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.